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Conclusions: The choice of the appropriate method of 
irradiation (3DCRT vs dynamic techniques) and using the 
appropriate margin determining the image verification 
method (daily verification vs verification for the first 
fractions) significantly affects the average doses in the 
bladder and rectum. 
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Purpose/Objective: Radiation-induced dysphagia is an 
undesirable toxicity in head and neck cancer (HNC) 
treatment. Radiotherapy (RT) delivered with HT might 
mitigate this toxicity. This is a retrospective review of HT 
treatment plans relating planning target volumes (PTVs) and 
organs-at-risk (OAR) dosimetry to severe toxicities.  
Materials and Methods: Seventy two HNC patients treated 
with curative HT were included, 55% of whom had stage IV 
disease and 47% localised in the oral cavity and oropharynx. 
Dose for definitive RT was 70 Gy and for post-operative RT 
60-66 Gy. 47% of patients received a simultaneously 
integrated boost. Severe G3-4 early and chronic toxicities 
(CTCAE version 3.0 and RTOG/EORTC scoring system) were 
scored and correlated with common risk factors. Dose 
distributions to PTVs and OARs were correlated to severe 
toxicities and treatment effectiveness, using COX regression 
and contingency analysis. Overall treatment time of radiation 
therapy (TTT) was reported, with 10 patients having been 
replanned during RT due to anatomical changes.  
Results: Age resulted in more acute severe toxicity. Older 
patients (>64y) had more pain and xerostomia (p=<0.0001) 
and younger patients had more dysphagia and dermitis 
(p=<0.0001) in a multivariate analysis. Median pathologic PTV 
volume was 131 cc (109-153 cc) and elective PTV 345cc (288-
402cc). We achieved excellent pathologic PTV coverage with 
the isodoses 95%, 98% and 2% covering 98%, 97% and 103% of 
volume, respectively. Isodoses 95%, 98% and 2% of elective 
PTV covered 100%, 98% and 127% of volume.  Severe early 
toxicities were 31% mucositis, 11% pain, 7% xerostomia, 52% 
dysphagia and 45% dermitis; 21% of patients developed severe 
chronic dysphagia. Larger p. PTVs (>131 cc) resulted in 
significant higher early dysphagia rates (64.8% vs. 35.14% 
(p=0.02)) and late dysphagia rates (47.9% vs. 52% (p=0.059)). 
Wider PTVs showed a trend of correlation to decreased 
overall survival rates (OS at 3y, 36% vs.74% (p=0.23)). 
Concerning TTT, only 24% of patients had a standard 
treatment duration (<47 days), 40% had an intermediate TTT 
prolongation deviation (47 to 54 days) and 8% an important 
TTT prolongation (>54 days) in TTT, with 29% of patients 
start treatment on Thursday or Friday. TTT was not related 
with acute or late severe toxicities, neither with OS. Patients 
replanned during treatment (10 p) experienced more acute 
toxicity (pain and xerostomia p<0.01), but not an improved in 
locorregional control or OS. Replanning induced significant 
longer TTT (p=0.0001).  
Conclusions: The use of HT improves the coverage of PTV 
volumes preserving salivary glands, even in great volumes. 
Higher doses to ipsilateral parotid (28Gy) and submaxilar 
gland (58Gy) seem to be related to severe toxicity. 
Replanification is related to more toxicity without 
improvement in disease control. Different toxicities by ages 
can be related with other factors like HPV presence (younger 
patients) and basal atrophic salivary glands (older patients). 
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Purpose/Objective: This study aims to evaluate the 
geometric and actual dose delivery accuracy in supine and 
prone positions of breast tomotherapy. 
Materials and Methods: Forty early breast cancer patients 
were recruited for tomotherapy after breast conservation 
surgery. The breast cup size was ≥ C and TNM staging was T0-
T3, N0-N1, M0. All patients received 25 fractions of 
treatment with 2 Gy/fr to total 50 Gy. Thirty were treated in 
supine position on customized vaclok during planning and 
treatment and ten were treated in prone position 
immobilized on prone breast board with customized vaclok. 
Daily MVCT was performed for treatment verification. For 
lateral, longitudinal and vertical dimensions, the offset 
distances in terms of mm before couch adjustment were 
recorded; while for the roll dimension, the degree of angle 
rotated were recorded. The difference in coordinates before 
and after matching in these four dimensional directions were 
recorded in each fraction for each patient. Systematic (SE) 
and random (RE) errors were calculated from the 
